Guru Ownership Trend
Guru Analysis for Cardiol Therapeutics Inc. (CRDL)
Cardiol Therapeutics Inc. (CRDL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.46 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $595,067.71 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 236.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Cardiol Therapeutics Inc. (CRDL)
Major holders include Renaissance Technologies (RenTech) ($819,207), Steven Cohen ($19,455). According to the latest reported data, 2 tracked investment managers collectively hold approximately 791,191 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $595,067.71, with 2 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in CRDL during the most recent reporting period.
Yes, 1 managers opened new positions in CRDL, and 1 increased their existing holdings. The total reported buy value was $595,067.71.